Stock 7774 JAPAN TISSUE ENGINEERING CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Japan Tissue Engineering Co., Ltd.

Equities

7774

JP3389610001

Delayed Japan Exchange
Other stock markets
 10:30:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
666 JPY +0.91% Intraday chart for Japan Tissue Engineering Co., Ltd. +1.99% +31.62%
2023 Japan Tissue Engineering Co., Ltd. Provide Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
2023 Japan Tissue Engineering Co., Ltd. Provide Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Japan Tissue Engineering Co., Ltd. Provide Earnings Guidance for the Fiscal Year Ending March 31, 2024
CI
Japan Tissue Engineering Co., Ltd. Provide Earnings Guidance for the Fiscal Year Ending March 31, 2024
CI
Japan Tissue Engineering Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024
CI
Teijin, Japan Tissue Engineering to Team Up with Resilience US for Regenerative Medicine Technologies Development; Shares Climb 16%
MT
Teijin Limited and Japan Tissue Engineering Co., Ltd. Form Business Alliance to Spur Development of New Regenerative Medicine Technologies
CI
Japan Tissue Engineering Co., Ltd. Announces Marketing Approval for Autologous Cultured Epidermis Maintaining Melanocytes
CI
Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2023
CI
Japan Tissue Engineering Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2022
CI
Japan Tissue Engineering Co., Ltd. Reports Earnings Results for the Half Year Ended September 30, 2022
CI
Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2023
CI
Teijin, Japan Tissue, Others to Put Medicine Platform; Japan Tissue Shares Fall 4%
MT
Teijin, J-TEC, Mitsui Fudosan and NCC to Establish Regenerative Medicine Platform
CI
Japan Tissue Engineering Concludes an Agreement with ActualEyes
CI
Japan Tissue Engineering Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2023
CI
Japan Tissue Seeks Marketing Consent for Vitiligo Treatment Product
MT
Japan Tissue Engineering Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2022
CI
Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2023
CI
Japan Tissue Engineering Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 7774 Stock
  4. News Japan Tissue Engineering Co., Ltd.
  5. Highlights